The stability of monomeric intermediates controls amyloid formation: Aβ25-35 and its N27Q mutant

Biophysical Journal

Volumn 90, Issue 10, 2006, Pages 3365-3374

  Ma, Buyong ^a,c   Nussinov, Ruth ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[25-35];

ARTICLE; CONFORMATION; MOLECULAR DYNAMICS; MUTATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; SIMULATION;

EID: 33646192684     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.105.075309     Document Type: Article

References (37)

1. Bucciantini, M., E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, and M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
2. Houry, W. A., J. M. Sauder, H. Roder, and H. A. Scheraga. 1998. Definition of amide protection factors for early kinetic intermediates in protein folding. Proc. Natl. Acad. Sci. USA. 95:4299-4302.
3. Hao, M. H., and H. A. Scheraga. 1998. Molecular mechanisms for cooperative folding of proteins. J. Mol. Biol. 277:973-983.
4. Dobson, C. M. 2003. Protein folding and misfolding. Nature. 426:884-890.
5. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA. 95:13363-13383.
6. Isaacson, R. L., A. G. Weeds, and A. R. Fersht. 1999. Equilibria and kinetics of folding of gelsolin domain 2 and mutants involved in familial amyloidosis-Finnish type. Proc. Natl. Acad. Sci. USA. 96:11247-11252.
7. Dobson, C. M. 2001. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:133-145.
8. Mattson, M. P., J. G. Begley, R. J. Mark, and K. Furukawa. 1997. Aβ25-35 induces rapid lysis of red blood cells: contrast with Aβ1-42 and examination of underlying mechanisms. Brain Res. 771:147-153.
9. Pike, C. J., D. Burdick, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-1687.
10. Yankner, B. A., L. K. Duffy, and D. A. Kirschner. 1990. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:279-282.
11. Marchesi, V. T. 2005. An alternative interpretation of the amyloid Aβ hypothesis with regard to the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 102:9093-9098.
12. Lashuel, H. A., D. Hartley, B. M. Petre, T. Walz, and P. T. Lansbury Jr. 2002. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature. 418:291.
13. Lin, H., R. Bhatia, and R. Lal. 2001. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15:2433-2444.
14. Kagan, B. L., Y. Hirakura, R. Azimov, R. Azimova, and M. C. Lin. 2002. The channel hypothesis of Alzheimer's disease: current status. Peptides. 23:1311-1315.
15. Shanmugam, G., and R. Jayakumar. 2004. Structural analysis of amyloid β peptide fragment (25-35) in different microenvironments. Biopolymers. 76:421-434.
16. D'Ursi, A. M., M. R. Armenante, R. Guerrini, S. Salvadori, G. Sorrentino, and D. Picone. 2004. Solution structure of amyloid β-peptide (25-35) in different media. J. Med. Chem. 47:4231-4238.
17. Ippel, J. H., A. Olofsson, J. Schleucher, E. Lundgren, and S. S. Wijmenga. 2002. Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc. Natl. Acad. Sci. USA. 99:8648-8653.
18. Konno, T. 2001. Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's β(25-35) amyloid fibril. Biochemistry. 40:2148-2154.
19. Wagner, C., and T. Kiefhaber. 1999. Intermediates can accelerate protein folding. Proc. Natl. Acad. Sci. USA. 96:6716-6721.
20. Park, B. H., and M. Levitt. 1995. The complexity and accuracy of discrete state models of protein structure. J. Mol. Biol. 249:493-507.
21. Ma, B., and R. Nussinov. 2003. Energy landscape and dynamics of the β-hairpin G peptide and its isomers: Topology and sequences. Protein Sci. 12:1882-1893.
22. Ma, B., C. J. Tsai, and R. Nussinov. 2000. A systematic study of the vibrational free energies of polypeptides in folded and random states. Biophys. J. 79:2739-2753.
23. Lee, M. S., M. Feig, F. R. Salsbury, Jr., and C. L. Brooks 3rd. 2003. New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations. J. Comput. Chem. 24:1348-1356.
24. Hughes, E., R. M. Burke, and A. J. Doig. 2000. Inhibition of toxicity in the β-amyloid peptide fragment β-(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. J. Biol. Chem. 275:25109-25115.
25. Ma, B., and R. Nussinov. 2002. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16-22, Aβ16-35, and Aβ10-35): sequence effects. Proc. Natl. Acad. Sci. USA. 99:14126-14131.
26. Serpell, L. C. 2000. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta. 1502:16-30.
27. Inouye, H., P. E. Fraser, and D. A. Kirschner. 1993. Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: analysis by x-ray diffraction. Biophys. J. 64:502-519.
28. Chou, P. Y., and G. D. Fasman. 1978. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47:251-276.
29. Jun, B., and D. L. Weaver. 2002. One-dimensional potential barrier model of protein folding with intermediates. J. Chem. Phys. 116:418-426.
30. Urbanc, B., L. Cruz, S. Yun, S. V. Buldyrev, G. Bitan, D. B. Teplow, and H. E. Stanley. 2004. In silico study of amyloid β-protein folding and oligomerization. Proc. Natl. Acad. Sci. USA. 101:17345-17350.
31. Jang, H., C. K. Hall, and Y. Zhou. 2004. Assembly and kinetic folding pathways of a tetrameric β-sheet complex: molecular dynamics simulations on simplified off-lattice protein models. Biophys. J. 86:31-49.
32. Klimov, D. K., and D. Thirumalai. 2003. Dissecting the assembly of Aβ16-22 amyloid peptides into antiparallel b sheets. Structure. 11:295-307.
33. Chiti, F., M. Stefani, N. Taddei, G. Ramponi, and C. M. Dobson. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 424:805-808.
34. Fezoui, Y., and D. B. Teplow. 2002. Kinetic studies of amyloid β-protein fibril assembly. Differential effects of α-helix stabilization. J. Biol. Chem. 277:36948-36954.
35. Santini, S., G. Wei, N. Mousseau, and P. Derreumaux. 2004. Pathway complexity of Alzheimer's β-amyloid Aβ16-22 peptide assembly. Structure. 12:1245-1255.
36. Andrec, M., A. K. Felts, E. Gallicchio, and R. M. Levy. 2005. Protein folding pathways from replica exchange simulations and a kinetic network model. Proc. Natl. Acad. Sci. USA. 102:6801-6806.
37. Garcia, A. E., and J. N. Onuchic. 2003. Folding a protein in a computer: an atomic description of the folding/unfolding of protein A. Proc. Natl. Acad. Sci. USA. 100:13898-13903.